| Natera, Inc. | 1.55M | US$421M | 21.8% |
| Vera Therapeutics, Inc. | 2.79M | US$120M | 6.2% |
| Genmab A/s | 4.05M | US$111M | 5.7% |
| Rapport Therapeutics, Inc. | 1.9M | US$79.4M | 4.1% |
| Seaport Therapeutics, Inc. | 3.56M | US$77.4M | 4.0% |
| Arrivent Biopharma, Inc. | 1.7M | US$58.9M | 3.0% |
| Ultragenyx Pharmaceutical Inc. | 1.72M | US$57.3M | 3.0% |
| Bioage Labs, Inc. | 2.29M | US$56.2M | 2.9% |
| Bristol-myers Squibb Company | 877K | US$50.5M | 2.6% |
| Supernus Pharmaceuticals, Inc. | 1.04M | US$48.2M | 2.5% |
| Rhythm Pharmaceuticals, Inc. | 408K | US$45.3M | 2.3% |
| Gilead Sciences, Inc. | 343K | US$43.3M | 2.2% |
| United Therapeutics Corporation | 76,489 | US$41.4M | 2.1% |
| Cogent Biosciences, Inc. | 1.04M | US$40.1M | 2.1% |
| Axsome Therapeutics, Inc. | 160K | US$39.3M | 2.0% |
| Dyne Therapeutics, Inc. | 1.66M | US$36.8M | 1.9% |
| Immunome, Inc. | 1.72M | US$36.5M | 1.9% |
| Ideaya Biosciences, Inc. | 925K | US$34.5M | 1.8% |
| Anaptysbio, Inc. | 494K | US$33.3M | 1.7% |
| Nektar Therapeutics | 472K | US$32.9M | 1.7% |
| Arcus Biosciences, Inc. | 946K | US$29.2M | 1.5% |
| Inhibrx Biosciences, Inc. | 303K | US$28.7M | 1.5% |
| Biomarin Pharmaceutical Inc. | 359K | US$20.5M | 1.1% |
| Veradermics, Incorporated | 149K | US$18.3M | 0.95% |
| Insmed Incorporated | 158K | US$16.9M | 0.87% |
| Edgewise Therapeutics, Inc. | 381K | US$15.5M | 0.80% |
| Nurix Therapeutics, Inc. | 524K | US$12.7M | 0.66% |
| Design Therapeutics, Inc. | 865K | US$12.5M | 0.65% |
| Definium Therapeutics, Inc. | 256K | US$12M | 0.62% |
| First Tracks Biotherapeutics, Inc. | 565K | US$11.4M | 0.59% |
| Abbott Laboratories | 123K | US$11.2M | 0.58% |
| Disc Medicine, Inc. | 146K | US$10.7M | 0.55% |
| Tenax Therapeutics, Inc. | 500K | US$7.28M | 0.38% |
| Sionna Therapeutics, Inc. | 144K | US$6.35M | 0.33% |
| Absci Corporation | 337K | US$3.91M | 0.20% |
| Mirum Pharmaceuticals, Inc. | 27,591 | US$3.23M | 0.17% |
| Jade Biosciences, Inc. | 107K | US$2.39M | 0.12% |
| Savara, Inc. | 365K | US$2.25M | 0.12% |
| Praxis Precision Medicines, Inc. | 6,440 | US$2.16M | 0.11% |
| Septerna, Inc. | 47,506 | US$1.59M | 0.08% |
| Onkure Therapeutics, Inc. | 322K | US$1.47M | 0.08% |
| Sagimet Biosciences Inc. - Series A | 167K | US$1.29M | 0.07% |
| Aktis Oncology, Inc. | 32,436 | US$1.05M | 0.05% |
| Tyra Biosciences, Inc. | 32,267 | US$1.03M | 0.05% |
| Bolt Biotherapeutics, Inc. | 138K | US$530K | 0.03% |
| Nextcure, Inc. | 223K | US$356K | 0.02% |
| Imagenebio, Inc. | 31,884 | US$188K | <0.01% |
| Heartflow, Inc. | 5,079 | US$149K | <0.01% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Dexcom, Inc. | 0 | US$0 | 0.00% |
| Establishment Labs Holdings Inc. | 0 | US$0 | 0.00% |
| Harmony Biosciences Holdings, Inc. | 0 | US$0 | 0.00% |
| Oric Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Roivant Sciences Ltd. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Stryker Corporation | 0 | US$0 | 0.00% |
| Tango Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Xenon Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Zymeworks Inc. | 0 | US$0 | 0.00% |
| Acadia Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Axogen, Inc. | 0 | US$0 | 0.00% |
| Biogen Inc. | 0 | US$0 | 0.00% |
| Bridgebio Pharma, Inc. | 0 | US$0 | 0.00% |
| Celcuity Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |